“…Research methods designed to capitalize on mitonuclear interactions and detect incompatibilities as outlined in this review can be applied to other psychiatric disorders, as mitochondrial dysfunction is well documented in schizophrenia ( Goncalves et al, 2015 ; Hjelm et al, 2015 ; Monpays et al, 2016 ; Ben-Shachar, 2017 ; Ni and Chung, 2020 ; Roberts, 2020 ), depression ( Bansal and Kuhad, 2016 ; Allen et al, 2018 ; Caruso et al, 2019 ; Forester et al, 2019 ), autism ( Rossignol and Frye, 2012 ; Goh et al, 2014 ; Varga et al, 2018 ; Bennuri et al, 2019 ; Citrigno et al, 2020 ; Frye, 2020 ; Gevezova et al, 2020 ), and anxiety ( Chakravarty et al, 2013 ; Khalifeh et al, 2016 ; Babenko et al, 2018 ). The studies outlined in this review suggest that mitochondrial dysfunction underlying BD and other psychiatric disorders with genetic overlap may be the consequence of mitonuclear incompatibility, and may be enhanced in admixed populations with mitonuclear genomes originating from different ancestral populations ( Chou and Leu, 2015 ).…”